|$ in millions, except EPS amounts||Second Quarter 2013||Second Quarter 2012|
|Non-GAAP EPS that excludes items listed below 1||0.84||1.05|
|GAAP Net Income 2||906||1,793|
|Non-GAAP Net Income that excludes items listed below 1,2||2,530||3,227|
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced financial results for the second quarter of 2013.
Non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the second quarter of $0.84 exclude acquisition-related costs, restructuring costs and certain other items.